At-Home Foscarnet Administration in Patients with Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation: A Unicentric, Safe, and Feasible Program

• Main Authors: Sonia Ruiz-Boy (Author), Alexandra Pedraza (Author), Marta Prat (Author), Maria Queralt Salas (Author), Esther Carcelero (Author), Gisela Riu-Viladoms (Author), María Suárez-Lledó (Author), Inés Monge-Escartín (Author), Luis Gerardo Rodríguez-Lobato (Author), Alexandra Martínez-Roca (Author), Montserrat Rovira (Author), Carmen Martínez (Author), Cristina Gallego (Author), Álvaro Urbano-Ispizua (Author), Joan Sánchez (Author), María Ángeles Marcos (Author), Francesc Fernández-Avilés (Author)
• Format: Book
• Published: MDPI AG, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Cytomegalovirus (CMV) infection is a relevant cause of morbimortality in patients receiving allogeneic stem cell transplantation (allo-HCT). Foscarnet (FCN) is an effective drug against CMV administered intravenously and usually on an inpatient basis. The Home Care Unit (HCU) for hematologic patient...